Related Experiment Videos

DNA fragmentation in S49 lymphoma cells killed with glucocorticoids and other agents

Insights

Glucocorticoids cause DNA fragmentation in lymphoma cells, but this DNA cleavage is not specific to these hormones and may be a final step in cell death. Keywords: glucocorticoids, DNA fragmentation, lymphoma cells, cell death.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Endocrinology

Background:

  • Glucocorticoids are known to induce apoptosis in lymphoid cells.
  • The precise mechanisms underlying glucocorticoid-induced cell death are complex and not fully understood.

Purpose of the Study:

  • To investigate the effects of glucocorticoids on DNA integrity in mouse S49 lymphoma cells.
  • To determine if DNA cleavage is a specific marker of glucocorticoid action.

Main Methods:

  • Treatment of mouse S49 lymphoma cells with varying doses and durations of glucocorticoids.
  • Analysis of DNA integrity using gel electrophoresis to detect internucleosomal cleavage.
  • Comparison of DNA cleavage patterns induced by glucocorticoids with those induced by other agents like dibutyryl cyclic AMP, DNA synthesis inhibitors, and protein synthesis inhibitors.

Main Results:

  • Glucocorticoid treatment led to DNA cleavage at internucleosomal regions, dose- and time-dependently.
  • This DNA cleavage was observed only with glucocorticoids, suggesting steroid specificity.
  • Similar internucleosomal DNA fragmentation was induced by dibutyryl cyclic AMP, DNA synthesis inhibitors, and protein synthesis inhibitors (puromycin, cycloheximide).

Conclusions:

  • DNA fragmentation is not a specific early event in glucocorticoid-induced lymphocytolysis.
  • Internucleosomal DNA fragmentation may represent a common, final pathway in the programmed cell death of lymphoma cells, regardless of the initial trigger.
  • The findings suggest that while glucocorticoids initiate cell death, the observed DNA fragmentation is a downstream event.

Related Concept Videos